IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Provectus Biopharmaceutica (PVCT)

CUSIP: 74373P108 | NYSE | Healthcare · Biotechnology | Micro Cap | 82 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13D/APershing Edward52,441,27511.6%+3,185,381Jun 30, 2026No 13F filer matched
13DDominic Rodrigues25,220,5495.7%New 5%+ stakeDec 2, 2025No 13F filer matched
13D/APershing Edward52,441,275
11.6% of class · Jun 30, 2026+3,185,381
No 13F filer matched
13DDominic Rodrigues25,220,549
5.7% of class · Dec 2, 2025New 5%+ stake
No 13F filer matched

Institutional Holders — Q3 2026

Home Federal Bank of Tennessee100,000
0.0% of portfolio›$5.7K
Financial Symmetry Inc10,191
0.0% of portfolio›$582
StyleTurnoverLocationFiled
Home Federal Bank of Tennessee
100,000$5.7K0.0%ETFVery LowKnoxville, TN2026-10-15
Financial Symmetry Inc
10,191$5820.0%ETFVery LowRaleigh, NC2026-10-06